20.43 USD
+0.71 (+3.6%)
20.43 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to NRC. NRC was compared to 100 industry peers in the Health Care Providers & Services industry. NRC has an excellent profitability rating, but there are concerns on its financial health. NRC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NRC had positive earnings in the past year.
NRC had a positive operating cash flow in the past year.
NRC had positive earnings in each of the past 5 years.
Each year in the past 5 years NRC had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 12.03%, NRC belongs to the best of the industry, outperforming 97.00% of the companies in the same industry.
NRC has a Return On Equity of 116.86%. This is amongst the best in the industry. NRC outperforms 99.00% of its industry peers.
The Return On Invested Capital of NRC (21.81%) is better than 96.00% of its industry peers.
NRC had an Average Return On Invested Capital over the past 3 years of 37.14%. This is significantly above the industry average of 9.19%.
The 3 year average ROIC (37.14%) for NRC is well above the current ROIC(21.81%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.03% | ||
| ROE | 116.86% | ||
| ROIC | 21.81% |
ROA(3y)22.86%
ROA(5y)24.04%
ROE(3y)62.69%
ROE(5y)57.96%
ROIC(3y)37.14%
ROIC(5y)35.28%
1.3 Margins
The Profit Margin of NRC (11.76%) is better than 98.00% of its industry peers.
NRC's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 19.81%, NRC belongs to the best of the industry, outperforming 97.00% of the companies in the same industry.
NRC's Operating Margin has declined in the last couple of years.
NRC's Gross Margin of 62.05% is amongst the best of the industry. NRC outperforms 82.00% of its industry peers.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.81% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% |
OM growth 3Y-10.34%
OM growth 5Y-6.05%
PM growth 3Y-11.57%
PM growth 5Y-7.08%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, NRC has less shares outstanding
Compared to 5 years ago, NRC has less shares outstanding
NRC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.59 indicates that NRC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.59, NRC is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
NRC has a debt to FCF ratio of 6.45. This is a slightly negative value and a sign of low solvency as NRC would need 6.45 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.45, NRC is in line with its industry, outperforming 59.00% of the companies in the same industry.
NRC has a Debt/Equity ratio of 5.43. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.43, NRC is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.43 | ||
| Debt/FCF | 6.45 | ||
| Altman-Z | 3.59 |
ROIC/WACC2.48
WACC8.8%
2.3 Liquidity
NRC has a Current Ratio of 0.51. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.51, NRC is doing worse than 86.00% of the companies in the same industry.
A Quick Ratio of 0.51 indicates that NRC may have some problems paying its short term obligations.
With a Quick ratio value of 0.51, NRC is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 |
3. Growth
3.1 Past
The earnings per share for NRC have decreased strongly by -35.95% in the last year.
The Earnings Per Share has been decreasing by -3.77% on average over the past years.
NRC shows a decrease in Revenue. In the last year, the revenue decreased by -3.50%.
The Revenue has been growing slightly by 2.25% on average over the past years.
EPS 1Y (TTM)-35.95%
EPS 3Y-10.69%
EPS 5Y-3.77%
EPS Q2Q%-20.83%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 28.38, NRC can be considered very expensive at the moment.
61.00% of the companies in the same industry are more expensive than NRC, based on the Price/Earnings ratio.
NRC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.38 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRC is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRC is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.3 | ||
| EV/EBITDA | 15.19 |
4.3 Compensation for Growth
NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NRC has a Yearly Dividend Yield of 3.28%.
NRC's Dividend Yield is rather good when compared to the industry average which is at 0.59. NRC pays more dividend than 97.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, NRC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
5.2 History
The dividend of NRC decreases each year by -17.96%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
65.04% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
NRC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP65.04%
EPS Next 2YN/A
EPS Next 3YN/A
20.43
+0.71 (+3.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners49.6%
Inst Owner Change-0.15%
Ins Owners10.45%
Ins Owner Change2.76%
Market Cap462.94M
Revenue(TTM)139.10M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.58%
Short Ratio4.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
Yearly Dividend0.47
Dividend Growth(5Y)-17.96%
DP65.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.38 | ||
| Fwd PE | N/A | ||
| P/S | 3.33 | ||
| P/FCF | 37.3 | ||
| P/OCF | 17.81 | ||
| P/B | 30.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.19 |
EPS(TTM)0.72
EY3.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.55
FCFY2.68%
OCF(TTM)1.15
OCFY5.62%
SpS6.14
BVpS0.66
TBVpS-2.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.03% | ||
| ROE | 116.86% | ||
| ROCE | 28.4% | ||
| ROIC | 21.81% | ||
| ROICexc | 22.32% | ||
| ROICexgc | 79.94% | ||
| OM | 19.81% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% | ||
| FCFM | 8.92% |
ROA(3y)22.86%
ROA(5y)24.04%
ROE(3y)62.69%
ROE(5y)57.96%
ROIC(3y)37.14%
ROIC(5y)35.28%
ROICexc(3y)44.1%
ROICexc(5y)48.5%
ROICexgc(3y)275.8%
ROICexgc(5y)N/A
ROCE(3y)48.38%
ROCE(5y)45.95%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-22.2%
ROICexc growth 5Y-12.25%
OM growth 3Y-10.34%
OM growth 5Y-6.05%
PM growth 3Y-11.57%
PM growth 5Y-7.08%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.43 | ||
| Debt/FCF | 6.45 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 194.42% | ||
| Cap/Sales | 9.77% | ||
| Interest Coverage | 7.14 | ||
| Cash Conversion | 75.28% | ||
| Profit Quality | 75.86% | ||
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 | ||
| Altman-Z | 3.59 |
F-Score6
WACC8.8%
ROIC/WACC2.48
Cap/Depr(3y)235.57%
Cap/Depr(5y)169.24%
Cap/Sales(3y)9.25%
Cap/Sales(5y)6.89%
Profit Quality(3y)78.03%
Profit Quality(5y)88.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.95%
EPS 3Y-10.69%
EPS 5Y-3.77%
EPS Q2Q%-20.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.07%
EBIT growth 3Y-11.35%
EBIT growth 5Y-3.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.58%
FCF growth 3Y-21.17%
FCF growth 5Y-11.22%
OCF growth 1Y-24.68%
OCF growth 3Y-8.93%
OCF growth 5Y-3.08%
NATIONAL RESEARCH CORP / NRC FAQ
What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
Can you provide the valuation status for NATIONAL RESEARCH CORP?
ChartMill assigns a valuation rating of 2 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.
What is the profitability of NRC stock?
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?
The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 28.38 and the Price/Book (PB) ratio is 30.86.
Can you provide the financial health for NRC stock?
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.